Heat Biologics CEO Jeff Wolf talks with Contagion about the firm’s effort to develop a vaccine for the coronavirus focused on combining antibody and T cell immunity. “We have a very unique vaccine,” Wolf claims, pointing to advantages over existing…
Dr Benjamin Neuman is a virologist with 24 years experience in studying coronaviruses. He was part of the taxonomy study group that named the 2019 novel coronavirus (SARS-CoV-2) that causes COVID-19. Primarily through a Facebook group, he answers the public’s…
As the ongoing COVID-19 pandemic edges up on the onset of flu season, the need for effective vaccines for these viruses and others is abundantly clear. In this Front Row Lecture, Ian Wilson, DPhil, chair of Scripps Research’s Department of…
Heat Biologics, Inc. (NASDAQ:HTBX) CEO Jeff Wolf tells Proactive the North Carolina-based biopharma is continuing to advance its coronavirus vaccine in collaboration with researchers at the University of Miami. Wolf says Heat’s vaccine is being designed to clear virus infected…
Besides vaccines and antiviral drugs, a group of medicines called biologics offer great potential in the battle against COVID-19. Serum from recovered patients can be used to protect others and also to identify useful antibodies, our immune system’s precision germ-targeting…